{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T22:10:51Z","timestamp":1768083051152,"version":"3.49.0"},"reference-count":49,"publisher":"Spandidos Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.3892\/ol.2012.757","type":"journal-article","created":{"date-parts":[[2012,6,13]],"date-time":"2012-06-13T12:18:57Z","timestamp":1339589937000},"page":"385-389","source":"Crossref","is-referenced-by-count":16,"title":["HE4 protein and SMRP: Potential novel biomarkers in ovarian cancer detection"],"prefix":"10.3892","volume":"4","author":[{"given":"ANNA","family":"FRITZ-RDZANEK","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"WOJCIECH","family":"GRZYBOWSKI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JAROS\u0141AW","family":"BETA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ANDRZEJ","family":"DURCZY\u0143SKI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ARTUR","family":"JAKIMIUK","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2012,6,13]]},"reference":[{"key":"key20180108091732_b1-ol-04-03-0385","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3322\/canjclin.55.1.10","article-title":"Cancer statistics","volume":"55","author":"Jemal","year":"2005","journal-title":"CA Cancer J Clin"},{"key":"key20180108091732_b2-ol-04-03-0385","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/jcb.240590927","article-title":"The epidemiology of ovarian cancer","volume":"23","author":"Tortorelo-Luna","year":"1995","journal-title":"J Cell Bioch"},{"key":"key20180108091732_b3-ol-04-03-0385","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1757-2215-2-13","article-title":"Role of CA125 in predicting ovarian cancer survival - a review of the epidemiological literature","volume":"2","author":"Gupta","year":"2003","journal-title":"J Ovarian Res"},{"key":"key20180108091732_b4-ol-04-03-0385","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1158\/1055-9965.EPI-08-0150","article-title":"Effects of personal characteristics on serum CA125, mesothelin and HE4 levels in healthy postmenopausal women at high-risk for ovarian cancer","volume":"17","author":"Lowe","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"key20180108091732_b5-ol-04-03-0385","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.bpobgyn.2005.10.012","article-title":"Screening for ovarian cancer in the general population","volume":"20","author":"Chu","year":"2002","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"key20180108091732_b6-ol-04-03-0385","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.critrevonc.2006.03.003","article-title":"Molecular predictors of response and outcome in ovarian cancer","volume":"60","author":"Canevari","year":"2006","journal-title":"Crit Rev Oncol Hematol"},{"issue":"8","key":"key20180108091732_b7-ol-04-03-0385","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.humpath.2008.01.003","article-title":"Tumor cell type can be reproducibly diagnosed and is of independent prognostic significance in patients with maximally debulked ovarian carcinoma","volume":"39","author":"Gilks","year":"2008","journal-title":"Hum Pathol"},{"key":"key20180108091732_b8-ol-04-03-0385","volume-title":"Annual report on the results of treatment in gynecological cancer","author":"Pettersson","year":"1994"},{"key":"key20180108091732_b9-ol-04-03-0385","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.1158\/1078-0432.CCR-03-0409","article-title":"Selection of potential markers of epithelial ovarian cancer with gene expression arrays and recursive descent partition analysis","volume":"10","author":"Lu","year":"2004","journal-title":"Clin Cancer Res"},{"key":"key20180108091732_b10-ol-04-03-0385","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/jcb.240590926","article-title":"Prospective on ovarian cancer: why prevent?","volume":"23","author":"Hoskins","year":"1995","journal-title":"Cell Biochem Suppl"},{"key":"key20180108091732_b11-ol-04-03-0385","article-title":"Annual report on the results of treatment in gynecological cancer","author":"Pettersson","year":"1998","journal-title":"International Federation of Gynecology and Obstetrics"},{"key":"key20180108091732_b12-ol-04-03-0385","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1002\/1097-0142(19931115)72:10<3007::AID-CNCR2820721024>3.0.CO;2-N","article-title":"National survey of ovarian carcinoma VI. Critical assessment of current International Federation of Gynecology and Obstetrics staging system","volume":"72","author":"Nguyen","year":"1993","journal-title":"Cancer"},{"key":"key20180108091732_b13-ol-04-03-0385","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/978-3-540-37696-5_9","article-title":"Ovarian cancer prevention and early detection: mission impossible?","volume":"174","author":"Bast","year":"2007","journal-title":"Recent Results Cancer Res"},{"key":"key20180108091732_b14-ol-04-03-0385","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.ygyno.2007.08.009","article-title":"Combining multiple serum tumor markers improves detection of stage I epithelial ovarian cancer","volume":"107","author":"Zhang","year":"2007","journal-title":"Gynecol Oncol"},{"key":"key20180108091732_b15-ol-04-03-0385","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ygyno.2008.04.041","article-title":"Evaluation of biomarker panels for early stage ovarian cancer detection and monitoring for disease recurrence","volume":"110","author":"Havrilesky","year":"2008","journal-title":"Gynecol Oncol"},{"key":"key20180108091732_b16-ol-04-03-0385","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1158\/1078-0432.CCR-05-2007","article-title":"Bead-based ELISA assays for validation of ovarian cancer early detection markers","volume":"1","author":"Scholler","year":"2006","journal-title":"Clin Cancer Res"},{"key":"key20180108091732_b17-ol-04-03-0385","doi-asserted-by":"crossref","first-page":"639 e1","DOI":"10.1016\/j.ajog.2008.12.042","article-title":"Validation of serum biomarkers for detection of early-stage ovarian cancer","volume":"200","author":"Nosov","year":"2009","journal-title":"Am J Obstet Gynecol"},{"key":"key20180108091732_b18-ol-04-03-0385","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1038\/sj.bjc.6604630","article-title":"Prediction of ovarian cancer prognosis and response to chemotherapy by a serum-based multiparametric biomarker panel","volume":"99","author":"Oikonomopolou","year":"2008","journal-title":"Br J Cancer"},{"key":"key20180108091732_b19-ol-04-03-0385","first-page":"489","article-title":"Factors influencing serum Ca125II levels in healthy postmenopausal women","volume":"10","author":"Pauler","year":"2001","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"key20180108091732_b20-ol-04-03-0385","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/0028-2243(85)90130-3","article-title":"Use of CA125 antigen in diagnosis and monitoring of ovarian carcinoma","volume":"19","author":"Bast","year":"1995","journal-title":"Eur Obset Gyncol Reprod Biol"},{"key":"key20180108091732_b21-ol-04-03-0385","first-page":"33","article-title":"The present and future of biomarkers for the early detection of epithelial ovarian carcinoma","volume":"4","author":"Fishman","year":"1999","journal-title":"CME J Gynecol Oncol"},{"key":"key20180108091732_b22-ol-04-03-0385","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/oxfordjournals.humrep.a136832","article-title":"The Ca125 tumor-associated antigen: a review of literature","volume":"4","author":"Jacobs","year":"1989","journal-title":"Human Reprod"},{"key":"key20180108091732_b23-ol-04-03-0385","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1093\/jnci\/85.21.1748","article-title":"Elevation of multiple serum markers in patients with stage I ovarian cancer","volume":"85","author":"Wollas","year":"1993","journal-title":"JNCI"},{"key":"key20180108091732_b24-ol-04-03-0385","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1200\/JCO.2003.01.068","article-title":"Status of tumor markers in ovarian cancer screening","volume":"21","author":"Bast","year":"2003","journal-title":"J Clin Oncol"},{"key":"key20180108091732_b25-ol-04-03-0385","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1002\/1097-0142(19951115)76:10+<2004::AID-CNCR2820761317>3.0.CO;2-G","article-title":"Toward an optimal algorithm for ovarian cancer screening with longitudinal tumor markers","volume":"76","author":"Skates","year":"1995","journal-title":"Cancer"},{"key":"key20180108091732_b26-ol-04-03-0385","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1158\/1055-9965.EPI-08-1034","article-title":"Influence of ovarian cancer risk status on the diagnostic performance of the serum biomarkers mesothelin, HE4 and CA125","volume":"18","author":"Shah","year":"2009","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"key20180108091732_b27-ol-04-03-0385","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1074\/mcp.R400006-MCP200","article-title":"Progress and challenges in screening for early detection of ovarian cancer","volume":"3","author":"Jacobs","year":"2004","journal-title":"Mol Cell Proteomics"},{"key":"key20180108091732_b28-ol-04-03-0385","doi-asserted-by":"crossref","first-page":"e2633","DOI":"10.1371\/journal.pone.0002633","article-title":"Systematic evaluation of candidate blood markers for detecting ovarian cancer","volume":"3","author":"Palmer","year":"2008","journal-title":"PLoS One"},{"key":"key20180108091732_b29-ol-04-03-0385","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1073\/pnas.93.1.136","article-title":"Molecular cloning of mesothelin, a differentiation antigen present on mesothelium, mesotheliomas, and ovarian cancers","volume":"93","author":"Chang","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180108091732_b30-ol-04-03-0385","first-page":"181","article-title":"Characterization of the antigen (CAK1) recognized by monoclonal antibody K1 present on ovarian cancers and normal mesothelium","volume":"52","author":"Chang","year":"1992","journal-title":"Cancer Res"},{"key":"key20180108091732_b31-ol-04-03-0385","first-page":"361","article-title":"Peritoneal mesothelium and ovarian surface cells-shared characteristics","volume":"3","author":"Blaustein","year":"1984","journal-title":"Int J Gynecol Pathol"},{"key":"key20180108091732_b32-ol-04-03-0385","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/jemt.20306","article-title":"Structural changes and cell properties of human ovarian surface epithelium in ovarian pathophysiology","volume":"69","author":"Okamura","year":"2006","journal-title":"Microsc Res Tech"},{"key":"key20180108091732_b33-ol-04-03-0385","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S1470-2045(08)70308-5","article-title":"The cell of origin of ovarian epithelial tumours","volume":"9","author":"Dubeau","year":"2008","journal-title":"Lancet Oncol"},{"issue":"Suppl 2","key":"key20180108091732_b34-ol-04-03-0385","first-page":"263","article-title":"Detailed morphology of human ovarian surface epithelium focusing on its metaplastic and neoplastic capability","volume":"106","author":"Okamura","year":"2001","journal-title":"Ital J Anat Embryol"},{"key":"key20180108091732_b35-ol-04-03-0385","first-page":"151","article-title":"Pathogenesis of ovarian cancer: lessons from morphology and molecular biology and their clinical implications","volume":"27","author":"Kurman","year":"2008","journal-title":"Int J Gynecol Pathol"},{"key":"key20180108091732_b36-ol-04-03-0385","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ygyno.2004.07.039","article-title":"Combining CA125 and SMRP serum markers for diagnosis and early detection of ovarian carcinoma","volume":"95","author":"McIntosh","year":"2004","journal-title":"Gynecol Oncol"},{"key":"key20180108091732_b37-ol-04-03-0385","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.canlet.2006.03.029","article-title":"Development of a CA125-mesothelin cell adhesion assay as a screening tool for biologics discovery","volume":"247","author":"Scholler","year":"2007","journal-title":"Cancer Lett"},{"key":"key20180108091732_b38-ol-04-03-0385","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1158\/0008-5472.CAN-04-3924","article-title":"Human epididymis protein 4 (HE4) is a secreted glycoprotein that is overexpressed by serous and endometrioid ovarian carcinomas","volume":"65","author":"Drapkin","year":"2005","journal-title":"Cancer Res"},{"key":"key20180108091732_b39-ol-04-03-0385","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/modpathol.3800612","article-title":"Comprehensive analysis of HE4 expression in normal and malignant human tissues","volume":"19","author":"Galgano","year":"2006","journal-title":"Mod Pathol"},{"key":"key20180108091732_b40-ol-04-03-0385","first-page":"3695","article-title":"The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma","volume":"63","author":"Hellstr\u00f6m","year":"2003","journal-title":"Cancer Res"},{"key":"key20180108091732_b41-ol-04-03-0385","doi-asserted-by":"crossref","first-page":"18S","DOI":"10.1200\/jco.2006.24.18_suppl.5036","article-title":"Utility of a novel serum tumor biomarker HE4 in patients with uterine cancer","volume":"24","author":"Moore","year":"2006","journal-title":"J Clin Oncol"},{"key":"key20180108091732_b42-ol-04-03-0385","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.ygyno.2003.12.024","article-title":"Transcriptional targeting in ovarian cancer cells using the human epididymis protein 4 promoter","volume":"92","author":"Berry","year":"2004","journal-title":"Gynecol Oncol"},{"key":"key20180108091732_b43-ol-04-03-0385","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.ygyno.2007.10.017","article-title":"The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass","volume":"108","author":"Moore","year":"2007","journal-title":"Gynecol Oncol"},{"key":"key20180108091732_b44-ol-04-03-0385","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ygyno.2008.08.031","article-title":"A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass","volume":"112","author":"Moore","year":"2009","journal-title":"Gynecol Oncol"},{"key":"key20180108091732_b45-ol-04-03-0385","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1158\/1055-9965.EPI-08-0150","article-title":"Factors influencing serum CA125II levels in healthy postmenopausal woman at high-risk for ovarian cancer","volume":"17","author":"Pauler","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"key20180108091732_b46-ol-04-03-0385","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1158\/1055-9965.EPI-05-0334","article-title":"Mesothelin variant I is released from tumor cells as a diagnostic marker","volume":"15","author":"Hellstr\u00f6m","year":"2006","journal-title":"Cancer Epidemiol Biomarker Prev"},{"key":"key20180108091732_b47-ol-04-03-0385","doi-asserted-by":"crossref","first-page":"291","DOI":"10.2217\/17520363.2.3.291","article-title":"Early detection of ovarian cancer","volume":"2","author":"Das","year":"2008","journal-title":"Biomark Med"},{"key":"key20180108091732_b48-ol-04-03-0385","doi-asserted-by":"crossref","first-page":"e232","DOI":"10.1371\/journal.pmed.0050232","article-title":"Ovarian carcinoma subtypes are different diseases: implication for biomarker studies","volume":"5","author":"K\u00f6bel","year":"2008","journal-title":"PLoS Med"},{"key":"key20180108091732_b49-ol-04-03-0385","doi-asserted-by":"crossref","first-page":"4589","DOI":"10.1002\/pmic.200500093","article-title":"Characterization of serum biomarkers for detection of early stage ovarian cancer","volume":"5","author":"Kozak","year":"2005","journal-title":"Proteomics"}],"container-title":["Oncology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/ol.2012.757\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,9]],"date-time":"2020-07-09T01:54:48Z","timestamp":1594259688000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ol.2012.757"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6,13]]},"references-count":49,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2012,6,13]]},"published-print":{"date-parts":[[2012,9]]}},"alternative-id":["10.3892\/ol.2012.757"],"URL":"https:\/\/doi.org\/10.3892\/ol.2012.757","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,6,13]]}}}